Key facts
- Heads Up’s last known valuation is $7.0M (Aug 2021).
- It has raised $15.3M; the latest was Later Stage VC ($6.1M) in Jan 2025.
- Notable investors include Innosphere Ventures, Iron Yard Ventures, Boston Harbor Angels, Dorian Greenow, Innosphere Ventures Fund — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Heads Up
- ·The full record, as it builds
Funding rounds
No funding rounds for Heads Up are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Heads Up
Developer of a digital health platform designed to track and optimize health in real time as part of functional medicine programs. The company's platform provides a health dashboard that gives users complete control over their data, featuring advanced tools that sync data across devices, apps, and medical records to visualize and personalize biohacks, enabling the healthcare sector to self-manage more effectively and improve individual outcomes while increasing efficiency and reducing costs in healthcare systems worldwide.
- Sector
- Healthcare
- HQ
- Scottsdale, AZ, United States
- Founded
- 2014
- Employees
- 34
- Website
- headsuphealth.com/
- Ownership
- Privately Held (backing)
Heads Up doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Heads Up shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Heads Up in its N-PORT filings yet. We sweep new filings monthly.